Evidence map›Paper›PMID 34526129›Full record

ArticleParasites & vectors2021

Efficacy of fipronil/(S)-methoprene/eprinomectin/praziquantel (Broadline

Stefania Zanet, Simone Morelli, Angela Di Cesare, Stefano Bò, Donato Traversa, Wilfried Lebon, Frederic Beugnet, Giulia Simonato, Ezio Ferroglio

Open access · goldAbstract readClinical Trial, Veterinary
PubMed Full text at PMC Publisher
In one paragraph

Article in Parasites & vectors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Stefania ZanetDepartment of Veterinary Sciences, University of Turin, Turin, Italy.
Simone MorelliFaculty of Veterinary Medicine, University of Teramo, Teramo, Italy.
Angela Di CesareFaculty of Veterinary Medicine, University of Teramo, Teramo, Italy. adicesare@unite.it.
Stefano BòAmbulatorio Veterinario Bo-Ferro, Turin, Italy.
Donato TraversaFaculty of Veterinary Medicine, University of Teramo, Teramo, Italy.
Wilfried LebonBoehringer Ingelheim Animal Health, Lyon, France.
Frederic BeugnetBoehringer Ingelheim Animal Health, Lyon, France.
Giulia SimonatoDepartment of Animal Medicine, Production and Health, University of Padua, Padua, Italy.
Ezio FerroglioDepartment of Veterinary Sciences, University of Turin, Turin, Italy.
University of Teramo · ITBoehringer Ingelheim (France) · FRUniversity of Turin · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe present clinical field trial was conducted to assess the efficacy of a broad-spectrum parasiticide spot-on formulation containing eprinomectin (Broadline

methodsFifteen privately owned cats harboring at least one live adult T. callipaeda were included in the study. Cats were randomly allocated to an untreated control group of seven cats or to a Broadline

resultsSeven days after treatment, six of eight treated cats were negative for eyeworm infection per visual examination, and on Day 14 no eyeworms were found in the treated cats while the seven untreated cats were still infected (geometric mean: 1.97). All cats had inflammatory ocular signs at inclusion; on Day 14, five of eight treated cats had recovered while all untreated control cats were still symptomatic. All collected parasites were confirmed to be T. callipaeda by morphology and molecular characterization.

conclusionsA single treatment with Broadline

Indexed as

AnimalsAntiparasitic AgentsCat DiseasesCatsDrug CombinationsEyeFemaleInflammationIvermectinMaleMethoprenePetsPraziquantelPyrazolesRandom AllocationSpirurida InfectionsAntiparasitic AgentsDrug CombinationseprinomectinfipronilIvermectinMethoprenePraziquantelPyrazolesBroadline®CatEprinomectinThelazia callipaeda

Identifiers

PMID34526129
PMCPMC8442459
OpenAlexW3200069043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.